GL1X · GenesisL1 explorer

MolNFT v1 · #101660 · protein

Bond length analysis of the pqqc Y175F mutant structure shows evidence for bound pqq in the reduced form

4NY7 · Pyrroloquinoline-quinone synthase: “Bond length analysis of the pqqc Y175F mutant structure shows evidence for bound pqq in the reduced form”. X-ray diffraction, 2 ligands (PQQ, CL), 7 pockets (best druggability 0.80). MolNFT v1…

PDB
4NY7
Type
protein
Length
508 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pyrroloquinoline-quinone synthase
EC
1.3.3.11
UniProt
A6T9H1
Ligands
PQQ, CL
Pockets
7 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 72% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BPyrroloquinoline-quinone synthase (EC 1.3.3.11)protein25472% helix, 0% strandA6T9H1

Ligands and binding sites

  • PQQ · Pyrroloquinoline quinone · ligand · 2 copies · chains A, B
  • CL · Chloride ion · ion · 2 copies · chains A, B
  • GOL · Glycerol · additive · 10 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12000.800.9435empty
21180.790.9825PQQ, CL
31080.780.9825PQQ, CL
4760.760.9930empty
5980.360.7416empty

Interfaces

1 interface between chains.

  • A–B · 2227 Ų buried · 32 hydrogen bonds · protein-protein

Compared structures

  • 4NY7 · Bond length analysis of the PqqC Y175F mutant structure shows evidence for bound PQQ in… · the same entry in another collection · chain A against A, TM-score 1.00
  • A6T9H1 · AlphaFold monomer V2.0 prediction for pyrroloquinoline-quinone synthase (A6T9H1) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.